EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,454 | -55.4% | 17,784 | -45.1% | 0.00% | -50.0% |
| Q2 2023 | $629,389 | -22.7% | 32,376 | +12.8% | 0.00% | -50.0% |
| Q1 2023 | $814,474 | -14.1% | 28,709 | -11.5% | 0.00% | -20.0% |
| Q4 2022 | $947,958 | -6.4% | 32,431 | -15.4% | 0.01% | -16.7% |
| Q3 2022 | $1,013,000 | +186.2% | 38,330 | +435.5% | 0.01% | +100.0% |
| Q1 2022 | $354,000 | -29.1% | 7,158 | -26.9% | 0.00% | -25.0% |
| Q4 2021 | $499,000 | +77.6% | 9,793 | +45.5% | 0.00% | 0.0% |
| Q1 2021 | $281,000 | +9.3% | 6,729 | +21.9% | 0.00% | 0.0% |
| Q4 2020 | $257,000 | – | 5,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |